ExirNanoSina is a knowledge based company founded by Dr.Jafari, Professor of Mashhad medical university in 2011, with Iran Nanotechnology Initiative Council support. Nano liposomal Anticancer drug “PEGylated Liposomal Doxorubicin HCl 20mg/10ml” under the “SinaDoxosome” trademark name has been produced, for the first time in Middle East’ in 2012 at Sobhan Oncology Co. after getting MOH licenses in November 2011.

Researches at this company are mostly focused on formulation based on micelles, liposomes and nanoparticles with industrial production vision for parenteral, oral and topical applications. These pharmaceutic methods increase efficacy and reduce toxicity of drugs and make lifetime circulation of drugs longer.

Goals: ExirNanoSina Co. try to increase drug’s benefits by applying new methods and improve people life’s quality with the new methods. The company can also become a leading provider of nanoscience products at the regional and global levels, in addition to contributing to the advancement of the food and health industry, to illustrate the globalization of Iran's nanotechnology industry.